A global research collaboration has revealed how certain gut cells switch on pain signals, which can linger long after the ...

There is good news for those with acute pain, as the FDA has approved a first-of-its-kind pain medication, and it’s one ...

Three studies at the University of Zurich demonstrate that hypnosis alters activity in the large-scale functional networks of ...

GRAND FORKS — A Grand Forks man is celebrating the success of a relatively new procedure for amputees, which has changed his ...

Nerve Renew is a dietary supplement designed to address neurological problems and restore healthy nerve function. The formula ...

(THE CONVERSATION) Chronic pain affects hundreds of millions of people around the world. But the opioid crisis in North America led many health care providers to realize they relied too heavily on ...

Belief is your safe passage—the door through which all healing resides. Why? Because your perception is your reality.

Carnegie Mellon University neuroscientists have discovered connections between the globus pallidus and a rarely explored area of the brain.

Introducing Journavx: the FDA-approved non-opioid, non-addictive drug for acute pain. A major breakthrough in pain medication ...

The new drug will carry a list price of $15.50 per pill, making it many times more expensive than comparable opioids.

It's the first new pharmaceutical approach to treating pain in over 20 years, designed to eliminate risks of addiction and ...